S Waggoner
Overview
Explore the profile of S Waggoner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
413
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nagaraj A, Wang Q, Joseph P, Zheng C, Chen Y, Kovalenko O, et al.
Oncogene
. 2017 Oct;
37(3):403-414.
PMID: 28967908
Computation-based drug-repurposing/repositioning approaches can greatly speed up the traditional drug discovery process. To date, systematic and comprehensive computation-based approaches to identify and validate drug-repositioning candidates for epithelial ovarian cancer (EOC)...
2.
Singh S, Armstrong A, Robke J, Waggoner S, Debernardo R
Gynecol Oncol Case Rep
. 2014 Nov;
9:24-5.
PMID: 25426410
•Intra-thoracic chemotherapy is an option for heavily pre-treated patients with recurrent ovarian cancer.•HITeC is technically feasible and well tolerated.
3.
McCarroll M, Armbruster S, Frasure H, Gothard M, Gil K, Kavanagh M, et al.
Gynecol Oncol
. 2013 Dec;
132(2):397-402.
PMID: 24369301
Objective: More patient-centered programming is essential for endometrial cancer (EC) survivors needing to lose weight to reduce cardiovascular disease risk (CVD). The purpose of this study was to improve self-efficacy...
4.
Yao Z, Ray S, Waggoner S, Hahn Y
Viral Immunol
. 2002 Jan;
14(4):277-95.
PMID: 11792059
Hepatitis C virus (HCV) infection in humans is almost invariably associated with viral persistence and chronic hepatitis. HCV-induced chronic hepatitis is a major risk factor for the development of hepatocellular...
5.
Laport G, Fleming G, Waggoner S, Zimmerman T, Grinblatt D, Williams S
Bone Marrow Transplant
. 2001 May;
27(7):677-81.
PMID: 11360105
As docetaxel is known to have significant antineoplastic activity against breast and ovarian cancer, we explored its application as a peripheral blood stem cell mobilizing agent in 33 women with...
6.
Castro I, Connell P, Waggoner S, Rotmensch J, Mundt A
Am J Clin Oncol
. 2000 Oct;
23(5):521-5.
PMID: 11039516
Synchronous ovarian primaries are infrequently found in patients with endometrial cancer. Although numerous investigators have examined the characteristics of these women, most include patients with tumors of similar histology, which...
7.
Tran B, Connell P, Waggoner S, Rotmensch J, Mundt A
Am J Clin Oncol
. 2000 Oct;
23(5):476-80.
PMID: 11039507
Recent reports have suggested that the pathologic features of young patients with endometrial cancer are less favorable than previously thought. We retrospectively reviewed the characteristics and outcome of young patients...
8.
Mundt A, Waggoner S, Yamada D, Rotmensch J, Connell P
Gynecol Oncol
. 2000 Sep;
79(1):79-85.
PMID: 11006036
Purpose: The aim of this study was to evaluate age as a prognostic factor for recurrence in endometrial cancer patients treated with primary surgery. Methods: Between 1983 and 1998, 455...
9.
Rose P, Rodriguez M, Waggoner S, Greer B, Horowitz I, Fowler J, et al.
J Clin Oncol
. 2000 Aug;
18(16):2957-62.
PMID: 10944128
Purpose: Given the activity of prolonged oral etoposide in platinum and paclitaxel-resistant ovarian carcinoma, a phase I trial was conducted that combined increasing days of oral etoposide therapy with paclitaxel...
10.
Markman M, Blessing J, Alvarez R, Hanjani P, Waggoner S, Hall K
Gynecol Oncol
. 2000 Mar;
77(1):112-5.
PMID: 10739699
Objectives: The aim of this study was to develop an alternative effective and more convenient administration schedule for intravenous topotecan when used as palliative treatment in ovarian cancer. Methods: The...